Hainan Poly Pharm Co (SZSE:300630) Ending Cash Position : ¥344 Mil (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Hainan Poly Pharm Co Ending Cash Position?

Hainan Poly Pharm Co's Ending Cash Position for the quarter that ended in Sep. 2023 was ¥344 Mil.

Hainan Poly Pharm Co's quarterly Ending Cash Position declined from Mar. 2023 (¥530 Mil) to Jun. 2023 (¥370 Mil) and declined from Jun. 2023 (¥370 Mil) to Sep. 2023 (¥344 Mil).

Hainan Poly Pharm Co's annual Ending Cash Position increased from Dec. 2020 (¥355 Mil) to Dec. 2021 (¥439 Mil) and increased from Dec. 2021 (¥439 Mil) to Dec. 2022 (¥745 Mil).

Hainan Poly Pharm Co Ending Cash Position Historical Data

The historical data trend for Hainan Poly Pharm Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Poly Pharm Co Ending Cash Position Chart

Hainan Poly Pharm Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Ending Cash Position

Get a 7-Day Free Trial

151.19

197.36

355.49

438.87

745.16

Hainan Poly Pharm Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Ending Cash Position	Get a 7-Day Free Trial															144.74	745.16	530.38	370.24	343.96

Hainan Poly Pharm Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hainan Poly Pharm Co's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	438.866	+	306.29
	=	745

Hainan Poly Pharm Co's Ending Cash Position for the quarter that ended in Sep. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	370.24	+	-26.279
	=	344

Hainan Poly Pharm Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Hainan Poly Pharm Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Poly Pharm Co (SZSE:300630) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Poly Pharm Co Ltd (SZSE:300630) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

No.1509 Binsheng Road, 10th Floor, Zhejiang Province, Hangzhou, CHN, 310051

Website

http://www.hnpoly.com

Hainan Poly Pharm Co Ltd is a pharmaceutical manufacturer in China. It manufactures injections, oral solid formulations, dry suspension, and other active pharmaceutical ingredients. The products offered by the company include Azithromycin for Injection, Ganciclovir Sodium for Injection. Octreotide Acetate Injection, Trimebutine Maleate tablets, Desloratadine, Trimebutine Maleate, and GANCICLOVIR among others.

Executives

Fan De Zhu	Independent director
Xie Hui Fang	Supervisors
Pu Jian	Executives
Xu Zhao	Securities Affairs Representative
Shen Shi Hua	Executives
Zhou Mao	Directors, Directors, and Executives

Hainan Poly Pharm Co (SZSE:300630) Headlines

No Headlines